Literature DB >> 19158249

Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Mari I Jonsson1, Annasara E Lenman, Lars Frängsmyr, Cecilia Nyberg, Mohamed Abdullahi, Niklas Arnberg.   

Abstract

Most adenoviruses bind directly to the coxsackie and adenovirus receptor (CAR) on target cells in vitro, but recent research has shown that adenoviruses can also use soluble components in body fluids for indirect binding to target cells. These mechanisms have been identified upon addressing the questions of how to de- and retarget adenovirus-based vectors for human gene and cancer therapy, but the newly identified mechanisms also suggest that the role of body fluids and their components may also be of importance for natural, primary infections. Here we demonstrate that plasma, saliva, and tear fluid promote binding and infection of adenovirus type 5 (Ad5) in respiratory and ocular epithelial cells, which corresponds to the natural tropism of most adenoviruses, and that plasma promotes infection by Ad31. By using a set of binding and infection experiments, we also found that Ad5 and Ad31 require coagulation factors IX (FIX) or X (FX) or just FIX, respectively, for efficient binding and infection. The concentrations of these factors that were required for maximum binding were 1/100th of the physiological concentrations. Preincubation of virions with heparin or pretreatment of cells with heparinase I indicated that the role of cell surface heparan sulfate during FIX- and FX-mediated adenovirus binding and infection is mechanistically serotype specific. We conclude that the use of coagulation factors by adenoviruses may be of importance not only for the liver tropism seen when administering adenovirus vectors to the circulation but also during primary infections by wild-type viruses of their natural target cell types.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158249      PMCID: PMC2663266          DOI: 10.1128/JVI.02562-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Integrin alpha(v)beta1 is an adenovirus coreceptor.

Authors:  E Li; S L Brown; D G Stupack; X S Puente; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Adenovirus type 37 uses sialic acid as a cellular receptor.

Authors:  N Arnberg; K Edlund; A H Kidd; G Wadell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.

Authors:  Robert W Walters; Paul Freimuth; Thomas O Moninger; Ingrid Ganske; Joseph Zabner; Michael J Welsh
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  Vascular cell adhesion molecule-1 augments adenovirus-mediated gene transfer.

Authors:  Y Chu; D Heistad; M I Cybulsky; B L Davidson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

5.  High-efficiency gene transfer to primary T lymphocytes by recombinant adenovirus vectors.

Authors:  Zhi Chen; Matti Ahonen; Heli Hämäläinen; Jeffrey M Bergelson; Veli Matti Kähäri; Riitta Lahesmaa
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

6.  In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Authors:  Theodore Smith; Neeraja Idamakanti; Helen Kylefjord; Michele Rollence; Laura King; Michele Kaloss; Michael Kaleko; Susan C Stevenson
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

7.  Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells.

Authors:  Niklas Arnberg; Patricia Pring-Akerblom; Göran Wadell
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes.

Authors:  C T Garnett; D Erdman; W Xu; Linda R Gooding
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential.

Authors:  Emma C Nilsson; Fariba Jamshidi; Susanne M C Johansson; M Steven Oberste; Niklas Arnberg
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

10.  Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

Authors:  M C Dechecchi; P Melotti; A Bonizzato; M Santacatterina; M Chilosi; G Cabrini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

View more
  25 in total

1.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

2.  Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.

Authors:  Franziska Jönsson; Claudia Hagedorn; Florian Kreppel
Journal:  J Vis Exp       Date:  2018-10-26       Impact factor: 1.355

Review 3.  Barriers to systemic application of virus-based vectors in gene therapy: lessons from adenovirus type 5.

Authors:  Franziska Jönsson; Florian Kreppel
Journal:  Virus Genes       Date:  2017-07-28       Impact factor: 2.332

Review 4.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

5.  Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells.

Authors:  Annasara Lenman; Steffen Müller; Mari I Nygren; Lars Frängsmyr; Thilo Stehle; Niklas Arnberg
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

6.  Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate.

Authors:  Anne K Zaiss; Roger Lawrence; David Elashoff; Jeffrey D Esko; Harvey R Herschman
Journal:  J Biol Chem       Date:  2011-05-19       Impact factor: 5.157

7.  Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.

Authors:  Anne K Zaiss; Erin M Foley; Roger Lawrence; Lina S Schneider; Hamidreza Hoveida; Patrick Secrest; Arthur B Catapang; Yu Yamaguchi; Ramon Alemany; Dmitry M Shayakhmetov; Jeffrey D Esko; Harvey R Herschman
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Authors:  Zhili Xu; Qi Qiu; Jie Tian; Jeffrey S Smith; Gina M Conenello; Takashi Morita; Andrew P Byrnes
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

Review 9.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

10.  Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates.

Authors:  Soeren Hofmayer; Ijad Madisch; Sebastian Darr; Fabienne Rehren; Albert Heim
Journal:  BMC Genomics       Date:  2009-11-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.